New guidelines address primary cutaneous T-cell lymphoproliferative disorders
Topical steroids "are effective, but not great," commented Dr. Zelenetz, vice chairman of medical informatics at Memorial Sloan Kettering Cancer Center, New York; professor of medicine at Cornell University, New York; and chair of the NCCN Non-Hodgkin …
Read more on Skin and Allergy News Digital Network
Skin Allergy Medicine
No comments:
Post a Comment